Detalles de la búsqueda
1.
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).
Br J Haematol
; 175(5): 917-924, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27714772
2.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Lancet Oncol
; 16(16): 1691-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26549589
3.
Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial.
Transl Psychiatry
; 13(1): 113, 2023 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019884
4.
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Leukemia
; 35(9): 2517-2525, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603142
Resultados
1 -
4
de 4
1
Próxima >
>>